Back to top

messenger-rna: Archive

Sundeep Ganoria

Moderna Stock Trades Near 52-Week Low: Should You Buy, Hold or Sell?

Given the uncertainty around its top-line growth, short-term investors should exercise caution when investing in MRNA stock.

GSKPositive Net Change PFENegative Net Change MRKPositive Net Change MRNAPositive Net Change

Sundeep Ganoria

CRSP Stock Rises 25% in a Week: Time to Buy, Hold or Sell?

The rise in CRISPR Therapeutics' share price can be attributed to the better-than-expected Q4 results and a rating upgrade by a well-established financial services firm.

VRTXPositive Net Change BEAMPositive Net Change NTLAPositive Net Change CRSPPositive Net Change

Sundeep Ganoria

Should You Buy, Hold or Sell Moderna Stock Post Q4 Earnings Release?

Given the uncertainty around its revenue growth, we advise short-term investors to remain cautious when investing in MRNA stock.

GSKPositive Net Change PFENegative Net Change MRKPositive Net Change MRNAPositive Net Change

Zacks Equity Research

Moderna Poised to Report Q4 Earnings: Is a Beat in the Cards?

When MRNA reports fourth-quarter earnings, investors will likely focus on pipeline updates.

MRKPositive Net Change MRNAPositive Net Change SRPTPositive Net Change CRSPPositive Net Change

Zacks Equity Research

PFE Stock Rises on Reports of Averting Proxy Fight With Activist Investor

A Bloomberg article suggests activist investor Starboard cut Pfizer some slack by not nominating any director on the company's board this year.

PFENegative Net Change CTMXPositive Net Change CSTLPositive Net Change ERASPositive Net Change